Craft

BB Biotech

Stock Price

CHF36.7

2024-10-29

Market Capitalization

CHF2.2 B

2024-08-26

Revenue

CHF741.8 M

FY, 2020

BB Biotech Summary

Company Summary

Overview
BB Biotech is an investment company in the field of biotechnology. It invests mainly in companies operating in sectors such as oncology, infectious diseases, cardiovascular diseases, metabolic diseases, and autoimmune diseases. Its portfolio comprises Moderna, Ionis Pharmaceuticals, Argenx, Neurocrine Biosciences, Incyte, and others.
Type
Public
Status
Active
Founded
1993
HQ
Schaffhausen, CH | view all locations
Website
https://www.bbbiotech.ch/en/bb-biotech
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Mads Krogsgaard Thomsen

    Mads Krogsgaard Thomsen, Board Member

  • Thomas von Planta

LocationsView all

1 location detected

  • Schaffhausen, SH HQ

    Switzerland

    Schwertstrasse 6

BB Biotech Financials

Summary Financials

Net income (Q3, 2021)
(CHF208.4M)

Footer menu